These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36516609)

  • 1. Can the level of copper in the hippocampus witness type-II diabetes versus Alzheimer's disease?
    Hureau C
    EBioMedicine; 2023 Jan; 87():104403. PubMed ID: 36516609
    [No Abstract]   [Full Text] [Related]  

  • 2. Elevated galanin may predict the risk of type 2 diabetes mellitus for development of Alzheimer's disease.
    Zhang Z; Fang P; Shi M; Zhu Y; Bo P
    Mech Ageing Dev; 2015 Sep; 150():20-6. PubMed ID: 26253934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of hypoglycemia on the risk of Alzheimer's disease in elderly subjects with diabetes mellitus.
    Muratli S; Tufan F; Soyluk O; Bahat G; Karan MA
    Clin Interv Aging; 2015; 10():1789-91. PubMed ID: 26622173
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes and Alzheimer's Disease: Can Elevated Free Copper Predict the Risk of the Disease?
    Squitti R; Mendez AJ; Simonelli I; Ricordi C
    J Alzheimers Dis; 2017; 56(3):1055-1064. PubMed ID: 27983558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and biological relationship between Type II diabetes mellitus and Alzheimer's disease.
    Nicolls MR
    Curr Alzheimer Res; 2004 Feb; 1(1):47-54. PubMed ID: 15975085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology of type 2 diabetes and Alzheimer's disease: Exploring the mitochondria.
    Silzer TK; Phillips NR
    Mitochondrion; 2018 Nov; 43():16-24. PubMed ID: 29678670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
    Fiore V; De Rosa A; Falasca P; Marci M; Guastamacchia E; Licchelli B; Giagulli VA; De Pergola G; Poggi A; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):571-579. PubMed ID: 30854980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes, Alzheimer's disease and apolipoprotein genotype.
    Messier C
    Exp Gerontol; 2003 Sep; 38(9):941-6. PubMed ID: 12954480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding Alzheimer's disease: The important causative role of divalent copper ingestion.
    Brewer GJ
    Exp Biol Med (Maywood); 2019 Feb; 244(2):114-119. PubMed ID: 30727765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease as copper deficiency.
    Klevay LM
    Med Hypotheses; 2008; 70(4):802-7. PubMed ID: 17928161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective.
    Luchsinger JA
    Eur J Pharmacol; 2008 May; 585(1):119-29. PubMed ID: 18384771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.
    Cooper GJ
    Drugs; 2011 Jul; 71(10):1281-320. PubMed ID: 21770477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and Alzheimer's disease: An unforgettable relation.
    Ciudin A
    Endocrinol Nutr; 2016 May; 63(5):191-3. PubMed ID: 26826774
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease.
    Morabito MV; Berman DE; Schneider RT; Zhang Y; Leibel RL; Small SA
    Neurobiol Dis; 2014 May; 65():188-92. PubMed ID: 24440570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesvirus in the hippocampus as a cause of Alzheimer's disease.
    Ball MJ
    Arch Neurol; 1986 Apr; 43(4):313. PubMed ID: 3006646
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the key molecules involved in chronic copper exposure-aggravated memory impairment in transgenic mice of Alzheimer's disease using proteomic analysis.
    Yu J; Luo X; Xu H; Ma Q; Yuan J; Li X; Chang RC; Qu Z; Huang X; Zhuang Z; Liu J; Yang X
    J Alzheimers Dis; 2015; 44(2):455-69. PubMed ID: 25352456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorating effect of anti-Alzheimer's drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer's disease.
    Ahmed AS; Elgharabawy RM; Al-Najjar AH
    Exp Biol Med (Maywood); 2017 Jul; 242(13):1335-1344. PubMed ID: 28534431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links.
    Pakdin M; Toutounchian S; Namazi S; Arabpour Z; Pouladi A; Afsahi S; Poudineh M; Nasab MMM; Yaghoobpoor S; Deravi N
    Curr Diabetes Rev; 2022; 18(8):e051121197760. PubMed ID: 34749616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus.
    Furuta A; Price DL; Pardo CA; Troncoso JC; Xu ZS; Taniguchi N; Martin LJ
    Am J Pathol; 1995 Feb; 146(2):357-67. PubMed ID: 7856748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.